Clinical Trial Update: This is a Phase 1 Study in Which Healthy Volunteers and Participants with Chronic HBV Infection Will Receive HT-101 or Placebo and Will Be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing HT-101 to placebo in healthy volunteers and adults with chronic hepatitis B to evaluate safety, tolerability, pharmacokinetics, and an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HT-101

Snippet

Sponsor: Suzhou HepaThera Biotech Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED